Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

Cereno Scientific says its lead therapeutic candidate, CS1, appears to be able to reverse vascular remodeling associated with pulmonary arterial hypertension (PAH). The findings are based on new data ...

1 Department of Rehabilitation, Huadong Hospital, Fudan University, Shanghai, China 2 Department of Osteoarthropathy Rehabilitation, The Second Rehabilitation Hospital of Shanghai, Shanghai, China ...

Cardiac MRI and virology raised the suspicion of giant cell myocarditis. Concerned about the hemodynamic and respiratory deterioration, we initiated cardiac transplant therapy. A fatal ventricular ...